Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17392350rdf:typepubmed:Citationlld:pubmed
pubmed-article:17392350lifeskim:mentionsumls-concept:C0019764lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C0021027lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C0036421lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C0017270lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C0002085lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C1421563lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C1415497lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C0014290lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:17392350lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:17392350pubmed:issue9lld:pubmed
pubmed-article:17392350pubmed:dateCreated2007-8-13lld:pubmed
pubmed-article:17392350pubmed:abstractTextTo investigate the relationship of the polymorphic enhancer HS1,2 central to the 3' enhancer complex regulatory region (IgH3'EC) of the immunoglobulin heavy chain genes with systemic sclerosis (SSc) disease and compare it with HLA-DR and DQ associations.lld:pubmed
pubmed-article:17392350pubmed:languageenglld:pubmed
pubmed-article:17392350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17392350pubmed:citationSubsetIMlld:pubmed
pubmed-article:17392350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17392350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17392350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17392350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17392350pubmed:statusMEDLINElld:pubmed
pubmed-article:17392350pubmed:monthSeplld:pubmed
pubmed-article:17392350pubmed:issn0003-4967lld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:TrioloGGlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:FrezzaDDlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:ValentiniGGlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:De SantisMMlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:FerraccioliGGlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:TolussoBBlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:GiambraVVlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:BoselloSSlld:pubmed
pubmed-article:17392350pubmed:authorpubmed-author:VettoriSSlld:pubmed
pubmed-article:17392350pubmed:issnTypePrintlld:pubmed
pubmed-article:17392350pubmed:volume66lld:pubmed
pubmed-article:17392350pubmed:ownerNLMlld:pubmed
pubmed-article:17392350pubmed:authorsCompleteYlld:pubmed
pubmed-article:17392350pubmed:pagination1210-5lld:pubmed
pubmed-article:17392350pubmed:dateRevised2010-9-2lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:meshHeadingpubmed-meshheading:17392350...lld:pubmed
pubmed-article:17392350pubmed:year2007lld:pubmed
pubmed-article:17392350pubmed:articleTitlePolymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency.lld:pubmed
pubmed-article:17392350pubmed:affiliationDepartment of Biology Enrico Calef, University of Tor Vergata, Rome, Italy. frezza@uniroma2.itlld:pubmed
pubmed-article:17392350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17392350pubmed:publicationTypeComparative Studylld:pubmed
entrez-gene:3119entrezgene:pubmedpubmed-article:17392350lld:entrezgene
entrez-gene:3123entrezgene:pubmedpubmed-article:17392350lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17392350lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17392350lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17392350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17392350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17392350lld:pubmed